NO164024C - Analogifremgangsmaate for fremstilling av terapeutisk aktive enantiomerer av substituerte fenylazacykloalkaner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive enantiomerer av substituerte fenylazacykloalkaner.

Info

Publication number
NO164024C
NO164024C NO831040A NO831040A NO164024C NO 164024 C NO164024 C NO 164024C NO 831040 A NO831040 A NO 831040A NO 831040 A NO831040 A NO 831040A NO 164024 C NO164024 C NO 164024C
Authority
NO
Norway
Prior art keywords
group
carbon atoms
alkyl group
hydrogen
chem
Prior art date
Application number
NO831040A
Other languages
English (en)
Norwegian (no)
Other versions
NO831040L (no
NO164024B (no
Inventor
Folke Lars-Erik Arvidsson
Per Arvid Emil Carlsson
John Stephan Mikael Hjorth
Anette Margareta Johansson
Per Lennart Lindberg
John Lars Gunnar Nilsson
Domingo Sanchez
Kjell Anders Ivan Svensson
Haakan Vilhelm Wikstroem
Uli Alf Hacksell
Original Assignee
Per Arvid Emil Carlsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Per Arvid Emil Carlsson filed Critical Per Arvid Emil Carlsson
Publication of NO831040L publication Critical patent/NO831040L/no
Publication of NO164024B publication Critical patent/NO164024B/no
Publication of NO164024C publication Critical patent/NO164024C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
NO831040A 1982-03-30 1983-03-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive enantiomerer av substituerte fenylazacykloalkaner. NO164024C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8202023A SE446335B (sv) 1982-03-30 1982-03-30 Ren enantiomer av en metasubstituerad 3-fenyl-1-propylpiperidin

Publications (3)

Publication Number Publication Date
NO831040L NO831040L (no) 1983-10-03
NO164024B NO164024B (no) 1990-05-14
NO164024C true NO164024C (no) 1990-08-22

Family

ID=20346417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831040A NO164024C (no) 1982-03-30 1983-03-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive enantiomerer av substituerte fenylazacykloalkaner.

Country Status (17)

Country Link
EP (1) EP0097628B1 (fr)
JP (1) JPS58177971A (fr)
AT (1) ATE56705T1 (fr)
AU (1) AU564287B2 (fr)
CA (1) CA1202307A (fr)
DD (1) DD209621A5 (fr)
DE (1) DE3381885D1 (fr)
DK (1) DK162214C (fr)
ES (3) ES8405372A1 (fr)
FI (1) FI81088C (fr)
GB (1) GB2117771B (fr)
GR (1) GR79244B (fr)
HU (1) HU191290B (fr)
IE (1) IE55261B1 (fr)
NO (1) NO164024C (fr)
PT (1) PT76481B (fr)
SE (1) SE446335B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8305362D0 (sv) * 1983-09-30 1983-09-30 Astra Laekemedel Ab Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
JP2011057619A (ja) * 2009-09-10 2011-03-24 Tokai Univ 光学活性アミン化合物の製造方法、並びに、ジアステレオマー塩及びその製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50674B1 (en) * 1979-12-05 1986-06-11 Astra Laekemedel Ab Phenyl-azacycloakanes

Also Published As

Publication number Publication date
DE3381885D1 (de) 1990-10-25
ES521080A0 (es) 1984-06-01
FI81088C (fi) 1990-09-10
GB2117771B (en) 1985-12-04
PT76481A (en) 1983-04-01
GB2117771A (en) 1983-10-19
FI81088B (fi) 1990-05-31
EP0097628B1 (fr) 1990-09-19
FI831068A0 (fi) 1983-03-29
NO831040L (no) 1983-10-03
ES8602655A1 (es) 1985-12-01
IE55261B1 (en) 1990-07-18
EP0097628A2 (fr) 1984-01-04
ES8405372A1 (es) 1984-06-01
SE8202023L (sv) 1983-10-01
HU191290B (en) 1987-02-27
GR79244B (fr) 1984-10-22
NO164024B (no) 1990-05-14
DK162214C (da) 1992-03-16
GB8308657D0 (en) 1983-05-05
DD209621A5 (de) 1984-05-16
DK143483D0 (da) 1983-03-29
ES530186A0 (es) 1985-12-01
JPS6155906B2 (fr) 1986-11-29
IE830685L (en) 1983-09-30
DK162214B (da) 1991-09-30
AU564287B2 (en) 1987-08-06
EP0097628A3 (en) 1984-07-18
PT76481B (en) 1986-02-27
ES539031A0 (es) 1985-11-16
CA1202307A (fr) 1986-03-25
ATE56705T1 (de) 1990-10-15
JPS58177971A (ja) 1983-10-18
DK143483A (da) 1983-10-01
SE446335B (sv) 1986-09-01
FI831068L (fi) 1983-10-01
ES8601889A1 (es) 1985-11-16
AU1284583A (en) 1983-10-06

Similar Documents

Publication Publication Date Title
ES8609258A1 (es) Un procedimiento para preparar un derivado de octahidrobenzo(f) quinoleina
NO176603C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive 8-substituert-2-aminotetraliner
NO164024C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive enantiomerer av substituerte fenylazacykloalkaner.
SE8305362D0 (sv) Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds
TH919A (th) การเตรียมอนุพันธ์ 1-แอลคิล-2-อะมิโน-เททราลิน